DIABETES CARDIORENAL AND METABOLISM INSTITUTE (EIN 872944998) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

BILLIE HABARI

Phone

8187089942

Tax Period

2024-01-01 to 2024-12-31

DIABETES CARDIORENAL AND METABOLISM INSTITUTE, founded in 2021, is a small nonprofit in the Health Care sector that reported $158K in total revenue in fiscal year 2024. Revenue fell 61% from the prior year — a significant decline worth monitoring. Expenses of $138K left a modest 13% surplus.

Mission

TO OPTIMIZE THE PREVENTION AND MANAGEMENT OF DIABETES, CARDIO-RENAL & METABOLIC DISEASES THROUGH EVALUATION OF STATE-OF-THE-ART MEDICAL AND RESEARCH OUTCOMES AND CLINICAL EXPERIENCE BY LEADING GLOBAL EXPERTS, CREATING PRACTICAL MULTIDISCIPLINARY CLINICAL RECOMMENDATIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $150,000

Program Service Revenue $0

Investment Income $8,498

Other Revenue $0

TOTAL REVENUE $158,498

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $135,641

Other Expenses $138,491

TOTAL EXPENSES $138,491

Year-over-Year Comparison

	2024	2023	Change
Revenue	$158,498	$402,650	-0.6%
Expenses	$138,491	$311,725	-0.6%
Net Income	$20,007	$90,925	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$43,250

Total Directors

$43,250

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BILLIE HABARI	SECRETARY/TREASURER	10.00	Officer Director	$0	$0	$43,250
ALON SCHWARTZ	PRESIDENT	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$158,498	$138,491	$206,607	$20,007
2023	$402,650	$311,725	$186,600	$90,925
2022	$300,000	$204,325	$101,435	$95,675

DIABETES CARDIORENAL AND METABOLISM INSTITUTE